Related Experiment Video
Updated: Nov 19, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
Hemostatic strategies for uncontrolled bleeding: A comprehensive update
Annum Malik1,2, Fiza Ur Rehman1,2, Kifayat Ullah Shah2
1Nanosciences and Technology Department, National Centre for Physics, Quaid-i-Azam University Campus, Islamabad, Pakistan.
Uncontrolled internal bleeding is a major cause of death. This review explores traditional and novel hemostatic agents, including micro- and nano-based options, to improve treatment for internal hemorrhage.
Area of Science:
- Biomedical Engineering
- Materials Science
- Emergency Medicine
Background:
- Uncontrolled bleeding is a leading cause of mortality and morbidity, particularly from internal hemorrhage.
- Current treatments like pressure dressings and tourniquets are ineffective for deep internal injuries.
- There is a critical need for effective interventions to manage internal bleeding, especially in emergency and combat situations.
Purpose of the Study:
- To review traditional hemostatic agents used to augment hemostasis.
- To explore the potential of micro- and nano-based hemostatic agents.
- To highlight advancements in treating uncontrolled internal bleeding.
Main Methods:
- Literature review of hemostatic agents.
- Analysis of traditional agents (zeolites, chitosan, etc.).
- Examination of advanced agents (synthocytes, synthetic platelets).
Main Results:
- Traditional agents include mineral zeolites, chitosan, and anti-fibrinolytics.
- Emerging agents involve micro- and nano-based technologies like synthocytes and synthetic platelets.
- Current treatments are insufficient for internal bleeding.
Conclusions:
- Effective treatments for internal bleeding are urgently needed.
- Micro- and nano-based hemostatic agents show promise for future applications.
- Advancements in hemostatic agents are crucial for reducing mortality from hemorrhage.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis IV: Nursing Management

